Profile
QTI ABT BSX-PA SYK BSX MDT
Company Name QT Imaging Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $10.22M $197.57B $175.45B $145.54B $144.69B $111.76B
Employees 0.01K 114.00K 45.00K 52.00K 48.00K 95.00K
CEO Dr. Raluca Dinu Ph.D. Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Michael F. Mahoney Mr. Geoffrey Straub Martha
Ratings
QTI ABT BSX-PA SYK BSX MDT
Quant Rating Score 2 3 3 3 3
Quant Rating Sell Neutral Neutral Neutral Neutral
Trading
QTI ABT BSX-PA SYK BSX MDT
Last Close $0.5262 $113.91 $122.18 $381.79 $98.17 $87.16
High 52 $1.4 $120.98 $122.18 $392.15 $98.17 $92.27
Low 52 $0.35 $100.07 $122.18 $307.75 $59.92 $76.84
Price vs. 52 Week High -62.41 % -5.84 % 0 % -2.64 % 0 % -5.54 %
Price vs. 52 Week Low 50.34 % 13.83 % 0 % 24.06 % 63.84 % 13.43 %
Total Return
QTI ABT BSX-PA SYK BSX MDT
1 Month Return 19.86 % 0.55 % 0 % 2.96 % 8.56 % 7.12 %
3 Month Return -6.42 % -3.38 % 0 % 6.12 % 13.6 % -2.92 %
6 Month Return -22.74 % 8.82 % 0 % 14.09 % 26.82 % 7.26 %
9 Month Return -29.75 % 7.56 % 0 % 13.62 % 44.45 % 10.22 %
YTD Return 7.83 % 0.71 % 0 % 6.04 % 9.91 % 9.11 %
1 Year Return 0 % -0.02 % 0 % 21.71 % 61.04 % 1.29 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
QTI ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 1.97 % - 0.85 % - 3.2 %
Dividend Paid and Capex Coverage Ration (TTM) -272.54 % 1.45 % 2.95 % 2.09 % 2.95 % 1.35 %
Dividend Per Share (TTM) - 2.24 % - 3.24 % - 2.79 %
Payout Ratio (TTM) - 65.3 % 1.29 % 33.4 % 1.29 % 84.54 %
Growth
QTI ABT BSX-PA SYK BSX MDT
Asset Growth 201.99 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth -100 % -9.7 % 14.01 % 13.12 % 14.01 % 3.12 %
Revenue Growth -100 % -8.12 % 12.29 % 11.11 % 12.29 % 3.64 %
Revenue 3 Year -100 % 18.5 % 40.06 % 41.29 % 40.06 % 8.85 %
Revenue 5 Year -100 % 32.8 % 37.78 % 48.53 % 37.78 % 7.41 %
Revenue 10 Year -100 % 63.89 % 84.02 % 126.63 % 84.02 % 43.65 %
EBIT Growth 14.84 % -22.53 % 42.09 % 36.85 % 42.09 % -6.22 %
Net Income Growth 17.96 % -17.45 % 128.22 % 34.22 % 128.22 % -2.18 %
Net Income 3 Yeari Growth Per Share -111.38 % 30.18 % 1209.43 % 95.8 % 1209.43 % 3.26 %
Net Income 5 Yeari Growth Per Share -111.38 % 144.68 % -9.39 % -12.21 % -9.39 % -19.5 %
Net Income 10 Yeari Growth Per Share -111.38 % 98.34 % 1315.23 % 213.78 % 1315.23 % -9.48 %
Operating Income Growth 14.84 % -22.53 % 42.09 % 36.85 % 42.09 % -6.22 %
Operating Cash Flow Growth (CFG) 49.66 % -24.21 % 64.02 % 41.43 % 64.02 % 12.39 %
Operating 3 Year CFG -60.62 % -6.04 % 61.83 % 12.02 % 61.83 % 10.18 %
Operating 5 Year CFG -60.62 % 16.69 % 667.41 % 40.12 % 667.41 % -1.78 %
Operating 10 Year CFG -60.62 % 95.01 % 113.53 % 96.25 % 113.53 % 3.3 %
EPS Growth -86.21 % -16.24 % 140 % 33.87 % 140 % -2.12 %
EPS Diluted Growth -86.21 % -16.37 % 137.78 % 33.71 % 137.78 % -2.13 %
Book Value Per Share 1684.15 % 6.36 % 9.41 % 11.49 % 9.41 % -2.26 %
Share Holder 3 Year Equity Growth Per Share 712.8 % 20.39 % 22.66 % 40.57 % 22.66 % -1.1 %
Share Holder 5 Year Equity Growth Per Share 712.8 % 28.04 % 110.05 % 56.21 % 110.05 % 1.66 %
Share Holder 10 Year Equity Growth Per Share 712.8 % 36.91 % 172.19 % 104.97 % 172.19 % 94.93 %
Dividend Per Share Growth - 8.64 % -49.88 % 7.97 % -49.88 % 1.54 %
Dividend 3 Year Growth Per Share - 42.02 % -2.5 % 30.56 % -2.5 % 19.02 %
Dividend 5 Year Growth Per Share - 82.38 % - 59.67 % - 38.05 %
Dividend 10 Year Growth Per Share - 259.93 % - 183.29 % - 147.94 %
Debt Growth -60.94 % -10.4 % 2.26 % -0.41 % 2.26 % 6.91 %
Free Cash Flow Growth 49.95 % -35.17 % 86.32 % 54.03 % 86.32 % 13.54 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
QTI ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 53.42 % 54.7 % 67.3 % 62.47 % 67.3 % 62.65 %
Return on Assets TTM -217.41 % 7.76 % 4.7 % 8.19 % 4.7 % 4.76 %
Return on Equity TTM 604.28 % 14.74 % 8.91 % 18.49 % 8.91 % 8.64 %
Return on Capital Employed TTM -712.04 % 11.6 % 8.57 % 12.38 % 8.57 % 7.56 %
Net Income Per EBT TTM 156.75 % 85.08 % 81.24 % 85.68 % 81.24 % 83.18 %
EBT Per Ebit TTM 88.81 % 98.29 % 79.87 % 93.61 % 79.87 % 87.63 %
EBIT Per Revenue TTM -269.58 % 16.73 % 17.33 % 20.37 % 17.33 % 17.83 %
Cash Flow To Debt Ratio TTM -86.31 % 58.27 % 26.08 % 24.79 % 26.08 % 25.4 %
Receivables Turnover TTM 15.7 4.48 6.36 5.88 6.36 5.27
Payables Turnover TTM 2.44 4.63 5.74 6.17 5.74 5.19
Inventory Turnover TTM 0.59 2.74 1.89 1.56 1.89 2.25
Fixed Asset Turnover TTM 352.74 % 388.07 % 454.83 % 557.01 % 454.83 % 512.52 %
Asset Turnover TTM 57.93 % 55.43 % 41.78 % 50.13 % 41.78 % 36.65 %
Operating Cash Flow Per Share TTM -0.44 5.03 1.99 10.07 1.99 5.61
Free Cash Flow Per Share TTM -0.44 3.74 1.33 8.41 1.33 4.29
Cash Per Share TTM 7.2 % 449.02 % 169.89 % 1229.07 % 169.89 % 622.97 %
Operating Cash Flow Sales Ratio TTM -233.8 % 21.18 % 18.45 % 17.47 % 18.45 % 21.81 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.37 % 74.31 % 66.93 % 83.49 % 66.93 % 76.43 %
Cash Flow Coverage Ratios TTM -86.31 % 58.27 % 26.08 % 24.79 % 26.08 % 25.4 %
Price To Free Cash Flows Ratio TTM -1.08 30.46 73.59 45.41 73.63 20.32
Price To Operating Cash Flows Ratio TTM -1.06 22.64 49.22 37.9 49.24 15.53
Price Cash Flow Ratio TTM -1.06 22.64 49.22 37.9 49.24 15.53
Income Statement (TTM)
QTI ABT BSX-PA SYK BSX MDT
Revenue $0B $40.11B $14.24B $20.5B $14.24B $32.36B
Gross Profit $0B $22.13B $9.9B $13.1B $9.9B $21.15B
Gross Profit Ratio 0% 55.18% 69.49% 63.89% 69.49% 65.34%
EBITDA $-0B $10.61B $3.45B $4.93B $3.45B $8.2B
Net Income $-0.01B $5.72B $1.59B $3.17B $1.59B $3.68B
EPS Diluted -0.54 3.27 1.07 8.25 1.07 2.76
Balance Sheet (MRQ)
QTI ABT BSX-PA SYK BSX MDT
Long Term Debt $0B $14.55B $8.96B $11.26B $8.96B $24.77B
Total Liabilities $0.01B $34.39B $15.61B $21.32B $15.61B $39.56B
Total Equity $0.01B $38.83B $19.53B $18.59B $19.53B $50.42B
Total Investments $0.02B $1.18B $0.41B $0.08B $0.41B $8.34B
Total Debt $0B $15.87B $9.49B $13B $9.49B $26.05B
Total Assets $0.02B $73.21B $35.14B $39.91B $35.14B $89.98B
Cash Flow Statement (TTM)
QTI ABT BSX-PA SYK BSX MDT
Net Income $-0.01B $5.72B $1.59B $3.17B $1.59B $3.68B
Inventory $0B $-0.23B $-0.66B $-0.8B $-0.66B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-1.14B $-0.03B $-3.67B
Operating Cash Flow $-0B $7.26B $2.5B $3.71B $2.5B $6.79B
Capital Expenditure $0B $-2.2B $-0.8B $-0.58B $-0.8B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 113.45
AEMD Aethlon Medical, Inc. 0.6638
AFIB Acutus Medical, Inc. 0.057
AHCO AdaptHealth Corp. 10.52
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 224.23
ALUR Allurion Technologies Inc. 2.9299
AMIX Autonomix Medical, Inc. Common Stock 3.13
ANIK Anika Therapeutics, Inc. 16.07
AORT Artivion, Inc. 30.725
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.4199
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.57
AVNS Avanos Medical, Inc. 15.91
AXDX Accelerate Diagnostics, Inc. 1.07
AXGN AxoGen, Inc. 18.07
AXNX Axonics, Inc. 70.98
AZYO Aziyo Biologics, Inc. 1.49
Unlock